Riskpilot← Back to searchSign inGet full accessFANA ØRE-NESE-HALS AS
ASActiveOrg 981406826Hamrevegen 36, 5229 KalandseidetMedical specialists activities · NACE 8622Est. 20001 employeeswww.ønh.no
Revenue 2024
NOK 6,1M
+3% vs 2023
EBITDA margin
44.3%
+26% vs 2023
Equity ratio
92.4%
Financial strength
Net profit 2024
NOK 2,6M
+26% vs 2023
| Revenue | NOK 6,1M | +3% |
| EBITDA | NOK 2,7M | +26% |
| Net profit | NOK 2,6M | +26% |
| Total assets | NOK 18,8M | +19% |
| Equity | NOK 17,3M | +18% |
| Employees | 1 | — |
Legal name
FANA ØRE-NESE-HALS AS
Org number
981406826
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
11. januar 2000
Share capital
NOK 200 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legetjenester, herav prosjektere og gjennomføre medisinske forskningsprosjekter, selge medisinske artikler, hjelpemidler og teknisk utstyr samt investere i andre selskaper aksjer og eiendom.
Address
Hamrevegen 36, 5229 Kalandseidet
Website
www.ønh.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 925 | 5 452 | 6 636 | 5 935 | 6 124 |
| Staff expenses | −762 | −804 | −703 | −789 | −790 |
| EBITDA | 4 491 | 1 098 | 3 353 | 2 163 | 2 715 |
| Depreciation & amort. | −13 | −18 | −23 | −27 | −50 |
| EBIT | 4 478 | 1 080 | 3 330 | 2 136 | 2 665 |
| Net financials | 236 | 215 | 190 | 550 | 729 |
| Profit before tax | 4 714 | 1 295 | 3 520 | 2 686 | 3 394 |
| Tax | 1 037 | 285 | 774 | 591 | 747 |
| Net profit | 3 677 | 1 010 | 2 746 | 2 095 | 2 647 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 392 | 16 435 | 13 847 | 15 784 | 18 765 |
| Equity | 12 843 | 9 853 | 12 598 | 14 693 | 17 341 |
| Long-term debt | 0 | 0 | 0 | 0 | 254 |
| Short-term debt | 1 549 | 6 582 | 1 249 | 1 091 | 1 171 |
| Total debt | 1 549 | 6 582 | 1 249 | 1 091 | 1 424 |
EBITDA margin
44.3%
This company
15.8%
Market median
+180% vs market
20202024
Equity ratio
92.4%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
20202024
Net profit margin
43.2%
This company
8.1%
Market median
+433% vs market
20202024
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH Chief Executive Officer | Chief Executive Officer | 2000 |
HI Deputy Member | Deputy Member | 2000 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FANA ØRE-NESE-HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stein Helge Glad Nordahl | Chief Executive Officer | 0 companies |
| Heidi Irene Nordahl | Deputy Member | 0 companies |